188 related articles for article (PubMed ID: 19172988)
1. The complex interaction between APOE promoter and AD: an Italian case-control study.
Bizzarro A; Seripa D; Acciarri A; Matera MG; Pilotto A; Tiziano FD; Brahe C; Masullo C
Eur J Hum Genet; 2009 Jul; 17(7):938-45. PubMed ID: 19172988
[TBL] [Abstract][Full Text] [Related]
2. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
[TBL] [Abstract][Full Text] [Related]
3. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
[TBL] [Abstract][Full Text] [Related]
4. The APOE gene locus in frontotemporal dementia and primary progressive aphasia.
Seripa D; Bizzarro A; Panza F; Acciarri A; Pellegrini F; Pilotto A; Masullo C
Arch Neurol; 2011 May; 68(5):622-8. PubMed ID: 21555637
[TBL] [Abstract][Full Text] [Related]
5. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
[TBL] [Abstract][Full Text] [Related]
6. Association between polymorphisms in the promoter region of the apolipoprotein E (APOE) gene and Alzheimer's disease: A meta-analysis.
Xiao H; Gao Y; Liu L; Li Y
EXCLI J; 2017; 16():921-938. PubMed ID: 28900374
[TBL] [Abstract][Full Text] [Related]
7. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
[TBL] [Abstract][Full Text] [Related]
8. Gene- Gene Interaction between PPARG and APOE Gene on Late-Onset Alzheimer's Disease: A Case- Control Study in Chinese Han Population.
Wang S; Guan L; Luo D; Liu J; Lin H; Li X; Liu X
J Nutr Health Aging; 2017; 21(4):397-403. PubMed ID: 28346566
[TBL] [Abstract][Full Text] [Related]
9. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.
Wang JC; Kwon JM; Shah P; Morris JC; Goate A
Neurology; 2000 Dec; 55(11):1644-9. PubMed ID: 11113217
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E promoter polymorphisms (-491A/T and -427T/C) and Alzheimer's disease: no evidence of association in the Irish population.
Lynch CA; Brazil J; Cullen B; Coakley D; Gill M; Lawlor BA; Hawi Z
Ir J Med Sci; 2008 Mar; 177(1):29-33. PubMed ID: 18057979
[TBL] [Abstract][Full Text] [Related]
11. APOE genotype-function relationship: evidence of -491 A/T promoter polymorphism modifying transcription control but not type 2 diabetes risk.
Geng H; Law PP; Ng MC; Li T; Liang LY; Ge TF; Wong KB; Liang C; Ma RC; So WY; Chan JC; Ho YY
PLoS One; 2011; 6(10):e24669. PubMed ID: 22028770
[TBL] [Abstract][Full Text] [Related]
12. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.
Coon KD; Myers AJ; Craig DW; Webster JA; Pearson JV; Lince DH; Zismann VL; Beach TG; Leung D; Bryden L; Halperin RF; Marlowe L; Kaleem M; Walker DG; Ravid R; Heward CB; Rogers J; Papassotiropoulos A; Reiman EM; Hardy J; Stephan DA
J Clin Psychiatry; 2007 Apr; 68(4):613-8. PubMed ID: 17474819
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
[TBL] [Abstract][Full Text] [Related]
14. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.
Martin ER; Lai EH; Gilbert JR; Rogala AR; Afshari AJ; Riley J; Finch KL; Stevens JF; Livak KJ; Slotterbeck BD; Slifer SH; Warren LL; Conneally PM; Schmechel DE; Purvis I; Pericak-Vance MA; Roses AD; Vance JM
Am J Hum Genet; 2000 Aug; 67(2):383-94. PubMed ID: 10869235
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E -491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population.
Yang JD; Feng GY; Zhang J; Cheung J; St Clair D; He L; Ichimura K
Neurosci Lett; 2003 Oct; 350(1):25-8. PubMed ID: 12962909
[TBL] [Abstract][Full Text] [Related]
16. Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease.
Scassellati C; Zanardini R; Squitti R; Bocchio-Chiavetto L; Bonvicini C; Binetti G; Zanetti O; Cassetta E; Gennarelli M
Neurosci Lett; 2004 Feb; 356(2):119-22. PubMed ID: 14746878
[TBL] [Abstract][Full Text] [Related]
17. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
Lambert JC; Araria-Goumidi L; Myllykangas L; Ellis C; Wang JC; Bullido MJ; Harris JM; Artiga MJ; Hernandez D; Kwon JM; Frigard B; Petersen RC; Cumming AM; Pasquier F; Sastre I; Tienari PJ; Frank A; Sulkava R; Morris JC; St Clair D; Mann DM; Wavrant-DeVrièze F; Ezquerra-Trabalon M; Amouyel P; Hardy J; Haltia M; Valdivieso F; Goate AM; Pérez-Tur J; Lendon CL; Chartier-Harlin MC
Neurology; 2002 Jul; 59(1):59-66. PubMed ID: 12105308
[TBL] [Abstract][Full Text] [Related]
18. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.
Artiga MJ; Bullido MJ; Frank A; Sastre I; Recuero M; García MA; Lendon CL; Han SW; Morris JC; Vázquez J; Goate A; Valdivieso F
Hum Mol Genet; 1998 Nov; 7(12):1887-92. PubMed ID: 9811931
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.
Nicodemus KK; Stenger JE; Schmechel DE; Welsh-Bohmer KA; Saunders AM; Roses AD; Gilbert JR; Vance JM; Haines JL; Pericak-Vance MA; Martin ER
Neurogenetics; 2004 Dec; 5(4):201-8. PubMed ID: 15455263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
